Skip to main content

GeneGo Licenses GVK's Compound DB for Use with Pathway Software

NEW YORK (GenomeWeb News) - GVK Biosciences of Hyderabad, India, has licensed its Medicinal Chemistry Database to the software and data-services company GeneGo, the companies said today.
GeneGo plans to integrate the MedChem database into its Metacore and MetaDrug platforms.
GeneGo's vice president of business development, Julie Bryant, said the agreement marks the first time the company has licensed third-party content for use in its platforms.
Pharmaceutical researchers use GeneGo's MetaCore 4.3 to target, identify, and validate biomarkers for diseases and toxicity. They use its MetaDrug 4.2 to help predict human metabolism, toxicity, and the effects of small molecule compounds.
GVK's Medicinal Chemistry Database contains more than 650,000 compounds accompanied by biological and pharmacological information, according to the company.
Financial terms of the agreement were not released.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.